Quality and Experience
Quality Assurance:Providing the highest quality within given timelines is and has always been an essential element of iQ. To ensure high quality, patient safety and compliance to applicable laws (including ICH-GCP and local GCP), regional iQ sites for Japan, South Korea and Taiwan have an independent Quality Assurance team. For Chinese site, our Taiwanese site assures its quality.
All of our QA personnel have a wealth of GxP industry and CRO experience with multi-national study.
Some of examples of our QA services:
- Audits for all types of trials including medical devices
- Site audit
- Data management, statistical analysis and CSR Audit
- Third party vendor audit/inspection
- Expertise Consultation
iQ Phrama's SOP:iQ uses one SOP system having Work Instructions covering country specific tasks. Unlike mega-CROs, our SOP is simplified for Asian trials. iQ has a designated SOP committee whom members are assigned from each country so as to share country specific issues and to have a regular discussion on the current operation.
iQ's SOP committee monitors our authorities for any regulatory updates and changes to ensure our procedures comply with applicable laws.
Our Experience:iQ offers a full range of clinical development services for a wide variety of therapeutic indications including but not limited to:
- Adrenal/Pituitary Disorders
- Alzheimer’s Disease/CNS Disorders
- Bone Disease/Metabolism
- Cardiovascular Disease
- Cancer pain
- Diabetes/Obesity/Lipid Metabolism/Carbohydrate Metabolism
- Endocrine Disorders
- Female Health Care/Gynecological Endocrinology/ Reproductive Endocrinology
- Gastrointestinal Disorders
- Immunology/Autoimmune Disease/Rheumatoid Arthritis
- Infectious Disease
- Inflammatory Diseases/Immune Status/ Cell Response
- Ophthalmic Disorders
- Orthopedic Disorders
- Renal Disease
- Thyroid Disorders
Lung, Breast, Gastric, Liver, Kidney, Pancreas, Prostate, Urothelium, Endometrial, Cervix, Ovary, Malignant mesothelioma, Hematological carcinoma
For detailed study information, Please contact us